Salvianolic acid B attenuates hypercholesterolemia via modulating the gut microbiota and bile acid metabolism.
AI Summary
Key Findings
Abstract
Regulation of bile acid metabolism offers an effective approach of reducing hypercholesterolemia. Salvianolic acid B, a phenolic acid compound found in salvia miltiorrhiza Bge, has therapeutic effects on cardiovascular diseases. Nevertheless, insufficient is known concerning the impact on hypercholesterolemia. This study has investigated the cholesterol-lowering effect of salvianolic acid B and delved into its potential mechanism. Hypercholesterolemia mice model was induced by a high-cholesterol diet. We evaluated lipid parameters in serum and liver and examined pathology changes and gene expression alterations in liver. In addition, we examined the effect of salvianolic acid B on gut microbiota in colonic contents utilized 16S rRNA. Salvianolic acid B significantly decreased the levels of lipids in serum, improved lipid accumulation in liver, and significantly increased the feces bile acid content. RNA-seq analysis results showed that salvianolic acid B exerts a significant influence on primary bile acid biosynthesis. In addition, Salvianolic acid B enhanced the expression of cholesterol 7α-hydroxylase (CYP7A1) and sterol 27-hydroxylase(CYP27A1). Furthermore, salvianolic acid B inhibited the abundance of BSH-producing bacteria, and decreased the expression levels of farnesoid X receptor (FXR), fibroblast growth factor 15 (FGF-15), apical sodium-dependent bile acid transporter (ASBT) and ileum bile acid binding protein (I-BABP). Taken together, this study demonstrated that salvianolic acid B improved hypercholesterolemia by inhibiting the abundance of BSH-producing bacteria and ileum FXR/FGF-15 signaling to enhance the synthesis and excretion of bile acids.
Affiliation
Xinyu Meng
External References
- PubMed ID:
- 40334726
Comments
Sign in or create a free account to join the conversation.
Sign in to commentBe the first to comment.